Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy
This study is researching an experimental drug called linvoseltamab when combined with
another drug called dupilumab. The study is focused on patients who have IgE-mediated
food allergy. If the patient has an allergy, the immune system overreacts to an allergen
(eg, ...
Age: 18 - 50 years
Gender: All
JAK Inhibition in Food Allergy
This study will assess the role for an oral targeted medication, abrocitinib, as a new
treatment option for food allergy patients that would avoid injections. Abrocitinib,
which has successfully completed phase three trials for atopic dermatitis, could serve as
a sin...
Age: 18 - 50 years
Gender: All
A Registry for Patients With Food Allergy
The FARE Patient Registry will serve as a prospective, observational food allergy reporting system that stores detailed health and other basic information about patients' real-world experiences with food allergies, to encourage open sharing of de-identified data and par...
Age: Birth - 66+
Gender: All